206 related articles for article (PubMed ID: 10770221)
1. Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients.
Toogood AA; Taylor NF; Shalet SM; Monson JP
J Clin Endocrinol Metab; 2000 Apr; 85(4):1727-30. PubMed ID: 10770221
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
Stewart PM; Toogood AA; Tomlinson JW
Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677
[TBL] [Abstract][Full Text] [Related]
3. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
Swords FM; Carroll PV; Kisalu J; Wood PJ; Taylor NF; Monson JP
Clin Endocrinol (Oxf); 2003 Nov; 59(5):613-20. PubMed ID: 14616886
[TBL] [Abstract][Full Text] [Related]
4. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity.
Gelding SV; Taylor NF; Wood PJ; Noonan K; Weaver JU; Wood DF; Monson JP
Clin Endocrinol (Oxf); 1998 Feb; 48(2):153-62. PubMed ID: 9579226
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients.
Walker BR; Andrew R; MacLeod KM; Padfield PL
Clin Endocrinol (Oxf); 1998 Aug; 49(2):257-63. PubMed ID: 9828916
[TBL] [Abstract][Full Text] [Related]
6. Modulation of cortisol metabolism during treatment of acromegaly is independent of body composition and insulin sensitivity.
Frajese GV; Taylor NF; Jenkins PJ; Besser GM; Monson JP
Horm Res; 2004; 61(5):246-51. PubMed ID: 15004437
[TBL] [Abstract][Full Text] [Related]
7. DIFFERENTIAL REGULATION OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVITY IN PATIENTS WITH DIFFERING ETIOLOGIES OF HYPOPITUITARISM.
Agha A; Behan LA; Forde H; Taylor NF; Smith D; Thompson CJ; Drake WM; Monson JP
Endocr Pract; 2018 Oct; 24(10):875-881. PubMed ID: 29975580
[TBL] [Abstract][Full Text] [Related]
8. Low-dose growth hormone inhibits 11 beta-hydroxysteroid dehydrogenase type 1 but has no effect upon fat mass in patients with simple obesity.
Tomlinson JW; Crabtree N; Clark PM; Holder G; Toogood AA; Shackleton CH; Stewart PM
J Clin Endocrinol Metab; 2003 May; 88(5):2113-8. PubMed ID: 12727963
[TBL] [Abstract][Full Text] [Related]
9. Lack of regulation of 11beta-hydroxysteroid dehydrogenase type 1 during short-term manipulation of GH in patients with hypopituitarism.
Sigurjonsdottir HA; Andrew R; Stimson RH; Johannsson G; Walker BR
Eur J Endocrinol; 2009 Sep; 161(3):375-80. PubMed ID: 19549748
[TBL] [Abstract][Full Text] [Related]
10. Effects of growth hormone replacement on cortisol metabolism in hypopituitary patients treated with cortisone acetate.
Beentjes JA; Kerstens MN; Dullaart RP
Scand J Clin Lab Invest; 2001 Jul; 61(4):277-86. PubMed ID: 11465341
[TBL] [Abstract][Full Text] [Related]
11. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.
Isidori AM; Kaltsas GA; Perry L; Burrin JM; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2003 May; 58(5):601-11. PubMed ID: 12699442
[TBL] [Abstract][Full Text] [Related]
12. Modulation of glucocorticoid metabolism by the growth hormone - IGF-1 axis.
Agha A; Monson JP
Clin Endocrinol (Oxf); 2007 Apr; 66(4):459-65. PubMed ID: 17371460
[TBL] [Abstract][Full Text] [Related]
13. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies.
Moore JS; Monson JP; Kaltsas G; Putignano P; Wood PJ; Sheppard MC; Besser GM; Taylor NF; Stewart PM
J Clin Endocrinol Metab; 1999 Nov; 84(11):4172-7. PubMed ID: 10566668
[TBL] [Abstract][Full Text] [Related]
14. Sexual dimorphism in 11 beta hydroxysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity; a study in hypopituitary subjects.
Weaver JU; Taylor NF; Monson JP; Wood PJ; Kelly WF
Clin Endocrinol (Oxf); 1998 Jul; 49(1):13-20. PubMed ID: 9797842
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific dysregulation of cortisol metabolism in human obesity.
Rask E; Olsson T; Söderberg S; Andrew R; Livingstone DE; Johnson O; Walker BR
J Clin Endocrinol Metab; 2001 Mar; 86(3):1418-21. PubMed ID: 11238541
[TBL] [Abstract][Full Text] [Related]
16. Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegaly.
Trainer PJ; Drake WM; Perry LA; Taylor NF; Besser GM; Monson JP
J Clin Endocrinol Metab; 2001 Jul; 86(7):2989-92. PubMed ID: 11443156
[TBL] [Abstract][Full Text] [Related]
17. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
Drake WM; Coyte D; Camacho-Hübner C; Jivanji NM; Kaltsas G; Wood DF; Trainer PJ; Grossman AB; Besser GM; Monson JP
J Clin Endocrinol Metab; 1998 Nov; 83(11):3913-9. PubMed ID: 9814468
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue.
Paulsen SK; Pedersen SB; Jørgensen JO; Fisker S; Christiansen JS; Flyvbjerg A; Richelsen B
J Clin Endocrinol Metab; 2006 Mar; 91(3):1093-8. PubMed ID: 16368752
[TBL] [Abstract][Full Text] [Related]
19. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults.
Weaver JU; Thaventhiran L; Noonan K; Burrin JM; Taylor NF; Norman MR; Monson JP
Clin Endocrinol (Oxf); 1994 Nov; 41(5):639-48. PubMed ID: 7828353
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: a dose-finding study.
Toogood AA; Shalet SM
J Clin Endocrinol Metab; 1999 Jan; 84(1):131-6. PubMed ID: 9920073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
